HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tyrosinase-positive melanocyte distribution and induction of pigmentation in human piebald skin.

Abstract
White forelock and hypomelanotic macules of piebaldism have been revealed to have almost regularly distributed, dopa-positive melanocytes, though with lower density than normal, on separated epidermis despite previous reports describing few or no melanocytes in piebald spots. The melanocytes observed in piebald hypomelanotic spots seem to be classified into the following two types: (1) strongly dopa-positive and markedly hyperdendritic large cell type and (2) moderately dopa-positive and slightly hyperdendritic, oversized cell type. The former are primarily seen in hypomelanotic lesions, while the latter are seen in transitional lesions. The above difference seems to be associated with compensatory melanogenic function of melanocytes in vivo. Moreover, we have induced new hyperpigmented spots in hypomelanotic lesions, with the exception of white forelock, following therapy with oral methoxsalen plus ultraviolet A light.
AuthorsK Hayashibe, Y Mishima
JournalArchives of dermatology (Arch Dermatol) Vol. 124 Issue 3 Pg. 381-6 (Mar 1988) ISSN: 0003-987X [Print] United States
PMID3125793 (Publication Type: Journal Article)
Chemical References
  • Dihydroxyphenylalanine
  • Catechol Oxidase
  • Monophenol Monooxygenase
Topics
  • Catechol Oxidase (metabolism)
  • Child
  • Child, Preschool
  • Dihydroxyphenylalanine (metabolism)
  • Female
  • Humans
  • Male
  • Melanocytes (metabolism, pathology)
  • Monophenol Monooxygenase (metabolism)
  • PUVA Therapy
  • Pedigree
  • Pigmentation Disorders (drug therapy, genetics, metabolism, pathology)
  • Skin (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: